Emerging targeted therapy for relapsed refractory DLBCL encompasses more complex molecular abnormalities involving signaling pathways other than NF- κB as mechanism of resistance to immune-chemotherapy.
While this makes interpretation of the rise in creatinine testing more complex, if abnormalities are detected in electrolyte levels, this prompts an immediate clinical need to determine the creatinine level, and therefore creatinine testing is an important component of monitoring of electrolytes as well as for CKD itself.
More complex findings such as bronchial abnormalities, bubble-like lucencies, an associated cystic airspace and vascular convergence sign are also indicative of a high likelihood of malignancy.
These findings suggest that underlying genetic abnormalities may be more complex than previously assumed.
The identification of complex rearrangements suggests chromosome abnormalities are often more complex than what was once thought.
On the other hand, polypoid lesions in endometriosis patients often exhibit hyperplastic or metaplastic glands and sometimes also cytologic atypia (Parker et al., 2004), which indicates that their pathogenesis is much more complex and associated with marked cellular abnormalities.
Genetic alterations of LIS1, DCX, ARX, TUBA1A, VLDLR, RELN and more recently WDR62 genes cause migrational abnormalities along with more complex and subtle anomalies affecting cell proliferation and differentiation, i.e., neurite outgrowth, axonal pathfinding, axonal transport, connectivity and even myelination.
‡Includes only simple chromosomal abnormalities with 2 or fewer changes, but not those with complex abnormalities with 3 or more aberrations.
Recent attention, however, has focused on several abnormalities, which together suggest a more complex cause.
One that is located more centromeric is possibly associated with bad prognosis, complex abnormalities, and high-risk, as well as therapy-related, MDS.
